Primo Chemicals board approves merger of wholly owned subsidiary Flow Tech

Scheme filed with the NCLTStrategic Transactions View source PDF Explain this filing

PRIMO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+13.3%Reaction day

₹22.30

prior close

₹25.40

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+13.0% vs market

Commodity Chemicals peers, median of 58sector+0.2%+13.1% vs sector

On the reaction day the stock moved 13.0 pts more than Nifty Microcap 250 and 13.1 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+13.3+0.3+13.0+0.2+13.1

Next day

+26.9-1.3+28.2-0.9+27.8

+25.6-0.3+25.9+0.1+25.5

+18.9-0.6+19.4-0.8+19.6

+15.7-1.8+17.5-0.6+16.3

+17.1-1.8+19.0-1.8+18.9

+14.9-0.8+15.7-1.0+15.9

15d

+12.1-4.1+16.2-2.6+14.7

+5.4-9.4+14.8-7.8+13.2

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 58Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Primo Chemicals board approved the Draft Scheme of Amalgamation to merge its wholly owned subsidiary Flow Tech Chemicals Pvt Ltd into itself. Appointed Date is 1 October 2026. No cash or share consideration applies as Flow Tech is fully owned by PCL, so no change in shareholding pattern. The merger needs NCLT and other regulatory approvals. Rationale includes simpler group structure, reduced compliance costs, and operational synergies.

Likely market impact

No share dilution or cash outflow. Aims to simplify group structure and reduce costs. Subject to NCLT approval.